肥胖患者脂肪组织中肾上腺髓质素2及其受体表达改变
研究比较肥胖(伴或不伴2型糖尿病)与正常体重女性腹部皮下和内脏脂肪中AM2及其受体组分表达,发现肥胖者ADM2 mRNA升高但血清AM2降低、CALCRL表达下降,减重手术未改变血清AM2,提示肥胖脂肪组织AM2信号受抑。
要点
- 肥胖患者皮下和内脏脂肪ADM2 mRNA均升高,与是否合并糖尿病无关。
- 肥胖患者血清AM2显著降低,且减重手术后6-9个月未改变。
- 肥胖患者脂肪组织CALCRL表达下降,AM2信号通路受抑。
核心结论
- 肥胖患者脂肪组织中AM2信号受抑,涉及受体表达降低和配体可利用性下降,可能促进胰岛素抵抗及肥胖相关病理生理。
研究设计与样本
- 研究纳入肥胖(伴或不伴2型糖尿病)与正常体重女性,检测代谢参数、血清AM2及腹部皮下和内脏脂肪中ADM2和受体组分基因表达。
- 血清AM2在减重手术前和术后6至9个月评估,并在人脂肪细胞中评估AM2及其受体的表达/分泌。
主要发现
- 肥胖患者皮下和内脏脂肪ADM2 mRNA均高于正常体重者,无论是否合并糖尿病。
- 肥胖患者血清AM2显著低于正常体重者,但减重手术后未改变。
- AM2及其受体复合物主要由脂肪细胞表达,肥胖患者两处脂肪组织CALCRL表达均降低。
- 模拟肥胖脂肪组织微环境的物质孵育脂肪细胞可增加ADM2 mRNA,但降低培养基中AM2分泌和CALCRL mRNA表达。
临床怎么用
- 肥胖患者脂肪组织AM2信号受抑,提示AM2通路可能参与肥胖相关胰岛素抵抗,但尚不能用于临床监测或干预。
局限性
- 研究未报告样本量、具体数值及统计显著性指标,相关结论需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Adrenomedullin 2 (AM2) plays protective roles in the renal and cardiovascular systems. Recent studies in experimental animals demonstrated that AM2 is an adipokine with beneficial effects on energy metabolism. However, there is little information regarding AM2 expression in human adipose tissue. OBJECTIVE: To investigate the pattern and regulation of the expression of AM2 and its receptor component in human adipose tissue, in the context of obesity and type 2 diabetes. METHODS: We measured metabolic parameters, serum AM2, and expression of ADM2 and its receptor component genes in abdominal subcutaneous and visceral adipose tissue in obese (with or without type 2 diabetes) and normal-weight women. Serum AM2 was assessed before and 6 to 9 months after bariatric surgery. Expression/secretion of AM2 and its receptor were assessed in human adipocytes. RESULTS: ADM2 mRNA in both fat depots was higher in obese patients, whether diabetic or not. Although serum AM2 was significantly lower in obese patients, it was not changed after bariatric surgery. AM2 and its receptor complex were predominantly expressed by adipocytes, and the expression of CALCRL, encoding a component of the AM2 receptor complex, was lower in both fat depots of obese patients. Incubating adipocytes with substances mimicking the microenvironment of obese adipose tissue increased ADM2 mRNA but reduced both AM2 secretion into culture media and CALCRL mRNA expression. CONCLUSIONS: Our data indicate that AM2 signaling is suppressed in adipose tissue in obesity, involving lower receptor expression and ligand availability, likely contributing to insulin resistance and other aspects of the pathophysiology associated with obesity.
引用
- Kim J, Lee SK, Kim D, et al. Altered Expression of Adrenomedullin 2 and its Receptor in the Adipose Tissue of Obese Patients. J Clin Endocrinol Metab. 2020. PMID: 31642491. doi:10.1210/clinem/dgz066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。